TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States Lung Cancer Liquid Biopsy Market Report & Forecast 2022-2028

Global and United States Lung Cancer Liquid Biopsy Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 28 September 2022
  • Pages :85
  • Formats:
  • Report Code:SMR-7395239
OfferClick for best price

Best Price: $3480

Lung Cancer Liquid Biopsy Market Size, Share 2022


Market Analysis and Insights: Global Lung Cancer Liquid Biopsy Market

The global Lung Cancer Liquid Biopsy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lung Cancer Liquid Biopsy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lung Cancer Liquid Biopsy market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lung Cancer Liquid Biopsy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lung Cancer Liquid Biopsy market.

Global Lung Cancer Liquid Biopsy Scope and Market Size

Lung Cancer Liquid Biopsy market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Lung Cancer Liquid Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Lung Cancer Liquid Biopsy market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

CTCs

CtDNA

Exosomes And RNA

Others

Segment by Application

Clinics

Hospitals

Physicians' Office Laboratories

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

By Company

Biocept

Exosome Diagnostics

F. Hoffmann-La Roche

Qiagen

Accuragen

Agena Bioscience

Bard1

Bgi

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Lung Cancer Liquid Biopsy product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Lung Cancer Liquid Biopsy, with price, sales, revenue, and global market share of Lung Cancer Liquid Biopsy from 2019 to 2022.

Chapter 3, the Lung Cancer Liquid Biopsy competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Lung Cancer Liquid Biopsy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Lung Cancer Liquid Biopsy market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Lung Cancer Liquid Biopsy.

Chapter 13, 14, and 15, to describe Lung Cancer Liquid Biopsy sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Lung Cancer Liquid Biopsy Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global and United States Lung Cancer Liquid Biopsy Market Report & Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 85 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Lung Cancer Liquid Biopsy Revenue in Lung Cancer Liquid Biopsy Business (2017-2022) & (US$ Million) Introduction
1.2 Global Lung Cancer Liquid Biopsy Outlook 2017 VS 2022 VS 2028
1.2.1 Global Lung Cancer Liquid Biopsy Market Size for the Year 2017-2028
1.2.2 Global Lung Cancer Liquid Biopsy Market Size for the Year 2017-2028
1.3 Lung Cancer Liquid Biopsy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Lung Cancer Liquid Biopsy in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Lung Cancer Liquid Biopsy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Lung Cancer Liquid Biopsy Market Dynamics
1.4.1 Lung Cancer Liquid Biopsy Industry Trends
1.4.2 Lung Cancer Liquid Biopsy Market Drivers
1.4.3 Lung Cancer Liquid Biopsy Market Challenges
1.4.4 Lung Cancer Liquid Biopsy Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Lung Cancer Liquid Biopsy by Type
2.1 Lung Cancer Liquid Biopsy Market Segment by Type
2.1.1 CTCs
2.1.2 CtDNA
2.1.3 Exosomes And RNA
2.1.4 Others
2.2 Global Lung Cancer Liquid Biopsy Market Size by Type (2017, 2022 & 2028)
2.3 Global Lung Cancer Liquid Biopsy Market Size by Type (2017-2028)
2.4 United States Lung Cancer Liquid Biopsy Market Size by Type (2017, 2022 & 2028)
2.5 United States Lung Cancer Liquid Biopsy Market Size by Type (2017-2028)
3 Lung Cancer Liquid Biopsy by Application
3.1 Lung Cancer Liquid Biopsy Market Segment by Application
3.1.1 Clinics
3.1.2 Hospitals
3.1.3 Physicians' Office Laboratories
3.2 Global Lung Cancer Liquid Biopsy Market Size by Application (2017, 2022 & 2028)
3.3 Global Lung Cancer Liquid Biopsy Market Size by Application (2017-2028)
3.4 United States Lung Cancer Liquid Biopsy Market Size by Application (2017, 2022 & 2028)
3.5 United States Lung Cancer Liquid Biopsy Market Size by Application (2017-2028)
4 Global Lung Cancer Liquid Biopsy Competitor Landscape by Company
4.1 Global Lung Cancer Liquid Biopsy Market Size by Company
4.1.1 Top Global Lung Cancer Liquid Biopsy Companies Ranked by Revenue (2021)
4.1.2 Global Lung Cancer Liquid Biopsy Revenue by Player (2017-2022)
4.2 Global Lung Cancer Liquid Biopsy Concentration Ratio (CR)
4.2.1 Lung Cancer Liquid Biopsy Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Lung Cancer Liquid Biopsy in 2021
4.2.3 Global Lung Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Lung Cancer Liquid Biopsy Headquarters, Revenue in Lung Cancer Liquid Biopsy Business (2017-2022) & (US$ Million) Type
4.3.1 Global Lung Cancer Liquid Biopsy Headquarters and Area Served
4.3.2 Global Lung Cancer Liquid Biopsy Companies Revenue in Lung Cancer Liquid Biopsy Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Lung Cancer Liquid Biopsy Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Lung Cancer Liquid Biopsy Market Size by Company
4.5.1 Top Lung Cancer Liquid Biopsy Players in United States, Ranked by Revenue (2021)
4.5.2 United States Lung Cancer Liquid Biopsy Revenue by Players (2020, 2021 & 2022)
5 Global Lung Cancer Liquid Biopsy Market Size by Region
5.1 Global Lung Cancer Liquid Biopsy Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Lung Cancer Liquid Biopsy Market Size by Region (2017-2028)
5.2.1 Global Lung Cancer Liquid Biopsy Market Size by Region: 2017-2022
5.2.2 Global Lung Cancer Liquid Biopsy Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Lung Cancer Liquid Biopsy Market Size YoY Growth 2017-2028
6.1.2 North America Lung Cancer Liquid Biopsy Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Lung Cancer Liquid Biopsy Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Lung Cancer Liquid Biopsy Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Lung Cancer Liquid Biopsy Market Size YoY Growth 2017-2028
6.3.2 Europe Lung Cancer Liquid Biopsy Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Lung Cancer Liquid Biopsy Market Size YoY Growth 2017-2028
6.4.2 Latin America Lung Cancer Liquid Biopsy Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Lung Cancer Liquid Biopsy Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Lung Cancer Liquid Biopsy Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Biocept
7.1.1 Biocept Company Details
7.1.2 Biocept Business Overview
7.1.3 Biocept Lung Cancer Liquid Biopsy Introduction
7.1.4 Biocept Revenue in Lung Cancer Liquid Biopsy Business (2017-2022)
7.1.5 Biocept Recent Development
7.2 Exosome Diagnostics
7.2.1 Exosome Diagnostics Company Details
7.2.2 Exosome Diagnostics Business Overview
7.2.3 Exosome Diagnostics Lung Cancer Liquid Biopsy Introduction
7.2.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biopsy Business (2017-2022)
7.2.5 Exosome Diagnostics Recent Development
7.3 F. Hoffmann-La Roche
7.3.1 F. Hoffmann-La Roche Company Details
7.3.2 F. Hoffmann-La Roche Business Overview
7.3.3 F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Introduction
7.3.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biopsy Business (2017-2022)
7.3.5 F. Hoffmann-La Roche Recent Development
7.4 Qiagen
7.4.1 Qiagen Company Details
7.4.2 Qiagen Business Overview
7.4.3 Qiagen Lung Cancer Liquid Biopsy Introduction
7.4.4 Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2017-2022)
7.4.5 Qiagen Recent Development
7.5 Accuragen
7.5.1 Accuragen Company Details
7.5.2 Accuragen Business Overview
7.5.3 Accuragen Lung Cancer Liquid Biopsy Introduction
7.5.4 Accuragen Revenue in Lung Cancer Liquid Biopsy Business (2017-2022)
7.5.5 Accuragen Recent Development
7.6 Agena Bioscience
7.6.1 Agena Bioscience Company Details
7.6.2 Agena Bioscience Business Overview
7.6.3 Agena Bioscience Lung Cancer Liquid Biopsy Introduction
7.6.4 Agena Bioscience Revenue in Lung Cancer Liquid Biopsy Business (2017-2022)
7.6.5 Agena Bioscience Recent Development
7.7 Bard1
7.7.1 Bard1 Company Details
7.7.2 Bard1 Business Overview
7.7.3 Bard1 Lung Cancer Liquid Biopsy Introduction
7.7.4 Bard1 Revenue in Lung Cancer Liquid Biopsy Business (2017-2022)
7.7.5 Bard1 Recent Development
7.8 Bgi
7.8.1 Bgi Company Details
7.8.2 Bgi Business Overview
7.8.3 Bgi Lung Cancer Liquid Biopsy Introduction
7.8.4 Bgi Revenue in Lung Cancer Liquid Biopsy Business (2017-2022)
7.8.5 Bgi Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Lung Cancer Liquid Biopsy Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Lung Cancer Liquid Biopsy Market Trends
Table 3. Lung Cancer Liquid Biopsy Market Drivers
Table 4. Lung Cancer Liquid Biopsy Market Challenges
Table 5. Lung Cancer Liquid Biopsy Market Restraints
Table 6. Global Lung Cancer Liquid Biopsy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Lung Cancer Liquid Biopsy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Lung Cancer Liquid Biopsy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Lung Cancer Liquid Biopsy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Lung Cancer Liquid Biopsy Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Lung Cancer Liquid Biopsy Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Lung Cancer Liquid Biopsy Revenue Share by Player, 2017-2022
Table 13. Global Lung Cancer Liquid Biopsy Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lung Cancer Liquid Biopsy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biopsy as of 2021)
Table 15. Top Players of Lung Cancer Liquid Biopsy in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Lung Cancer Liquid Biopsy Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Lung Cancer Liquid Biopsy Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Lung Cancer Liquid Biopsy Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Lung Cancer Liquid Biopsy Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Lung Cancer Liquid Biopsy Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Lung Cancer Liquid Biopsy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Lung Cancer Liquid Biopsy Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Lung Cancer Liquid Biopsy Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Lung Cancer Liquid Biopsy Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Lung Cancer Liquid Biopsy Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Lung Cancer Liquid Biopsy Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Lung Cancer Liquid Biopsy Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Lung Cancer Liquid Biopsy Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Biocept Company Details
Table 31. Biocept Business Overview
Table 32. Biocept Lung Cancer Liquid Biopsy Product
Table 33. Biocept Revenue in Lung Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 34. Biocept Recent Development
Table 35. Exosome Diagnostics Company Details
Table 36. Exosome Diagnostics Business Overview
Table 37. Exosome Diagnostics Lung Cancer Liquid Biopsy Product
Table 38. Exosome Diagnostics Revenue in Lung Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 39. Exosome Diagnostics Recent Development
Table 40. F. Hoffmann-La Roche Company Details
Table 41. F. Hoffmann-La Roche Business Overview
Table 42. F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Product
Table 43. F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 44. F. Hoffmann-La Roche Recent Development
Table 45. Qiagen Company Details
Table 46. Qiagen Business Overview
Table 47. Qiagen Lung Cancer Liquid Biopsy Product
Table 48. Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 49. Qiagen Recent Development
Table 50. Accuragen Company Details
Table 51. Accuragen Business Overview
Table 52. Accuragen Lung Cancer Liquid Biopsy Product
Table 53. Accuragen Revenue in Lung Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 54. Accuragen Recent Development
Table 55. Agena Bioscience Company Details
Table 56. Agena Bioscience Business Overview
Table 57. Agena Bioscience Lung Cancer Liquid Biopsy Product
Table 58. Agena Bioscience Revenue in Lung Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 59. Agena Bioscience Recent Development
Table 60. Bard1 Company Details
Table 61. Bard1 Business Overview
Table 62. Bard1 Lung Cancer Liquid Biopsy Product
Table 63. Bard1 Revenue in Lung Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 64. Bard1 Recent Development
Table 65. Bgi Company Details
Table 66. Bgi Business Overview
Table 67. Bgi Lung Cancer Liquid Biopsy Product
Table 68. Bgi Revenue in Lung Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 69. Bgi Recent Development
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
List of Figures
Figure 1. Lung Cancer Liquid Biopsy Product Picture
Figure 2. Global Lung Cancer Liquid Biopsy Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Lung Cancer Liquid Biopsy Market Size 2017-2028 (US$ Million)
Figure 4. United States Lung Cancer Liquid Biopsy Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Lung Cancer Liquid Biopsy Market Size 2017-2028 (US$ Million)
Figure 6. United States Lung Cancer Liquid Biopsy Market Share in Global 2017-2028
Figure 7. Lung Cancer Liquid Biopsy Report Years Considered
Figure 8. Product Picture of CTCs
Figure 9. Product Picture of CtDNA
Figure 10. Product Picture of Exosomes And RNA
Figure 11. Product Picture of Others
Figure 12. Global Lung Cancer Liquid Biopsy Market Share by Type in 2022 & 2028
Figure 13. Global Lung Cancer Liquid Biopsy Market Size by Type (2017-2028) & (US$ Million)
Figure 14. Global Lung Cancer Liquid Biopsy Market Share by Type (2017-2028)
Figure 15. United States Lung Cancer Liquid Biopsy Market Share by Type in 2022 & 2028
Figure 16. United States Lung Cancer Liquid Biopsy Market Size by Type (2017-2028) & (US$ Million)
Figure 17. United States Lung Cancer Liquid Biopsy Market Share by Type (2017-2028)
Figure 18. Product Picture of Clinics
Figure 19. Product Picture of Hospitals
Figure 20. Product Picture of Physicians' Office Laboratories
Figure 21. Global Lung Cancer Liquid Biopsy Market Share by Application in 2022 & 2028
Figure 22. Global Lung Cancer Liquid Biopsy Market Size by Application (2017-2028) & (US$ Million)
Figure 23. Global Lung Cancer Liquid Biopsy Market Share by Application (2017-2028)
Figure 24. United States Lung Cancer Liquid Biopsy Market Share by Application in 2022 & 2028
Figure 25. United States Lung Cancer Liquid Biopsy Market Size by Application (2017-2028) & (US$ Million)
Figure 26. United States Lung Cancer Liquid Biopsy Market Share by Application (2017-2028)
Figure 27. North America Lung Cancer Liquid Biopsy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 28. U.S. Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Canada Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Europe Lung Cancer Liquid Biopsy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 31. Germany Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. France Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. U.K. Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Italy Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Russia Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Lung Cancer Liquid Biopsy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 37. China Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Japan Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. South Korea Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. India Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Australia Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Taiwan Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Indonesia Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Thailand Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Malaysia Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Philippines Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Latin America Lung Cancer Liquid Biopsy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 48. Mexico Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Brazil Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Argentina Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Lung Cancer Liquid Biopsy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 52. Turkey Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. U.A.E Lung Cancer Liquid Biopsy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Biocept Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2017-2022)
Figure 56. Exosome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2017-2022)
Figure 57. F. Hoffmann-La Roche Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2017-2022)
Figure 58. Qiagen Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2017-2022)
Figure 59. Accuragen Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2017-2022)
Figure 60. Agena Bioscience Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2017-2022)
Figure 61. Bard1 Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2017-2022)
Figure 62. Bgi Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2017-2022)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount